Douglas Galasko
- Physiology top 1%
- Psychiatry and Mental health top 0.5%
- Neurology top 2%
- Molecular Biology
- Neurology top 2%
- Co-authors
- Eliezer MasliahL. J. ThalLawrence A. HansenDavid P. SalmonRobert D. TerryL A HansenL. Robert HillRobert Katzman
- Topics
- Dementia and Cognitive Impairment Research (22 papers)Alzheimer's disease research and treatments (21 papers)Cholinesterase and Neurodegenerative Diseases (7 papers)
- Partner nations
- United StatesCanadaDenmark
In The Last Decade
Douglas Galasko
43 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 126
- Physiology 1.7k
- Psychiatry and Mental health 1.5k
- Neurology 613
- Molecular Biology 487
- Neurology 464
Countries citing papers authored by Douglas Galasko
This map shows the geographic impact of Douglas Galasko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Galasko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Galasko more than expected).
Fields of papers citing papers by Douglas Galasko
This network shows the impact of papers produced by Douglas Galasko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Galasko. The network helps show where Douglas Galasko may publish in the future.
Co-authorship network of co-authors of Douglas Galasko
This figure shows the co-authorship network connecting the top 25 collaborators of Douglas Galasko. A scholar is included among the top collaborators of Douglas Galasko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas Galasko. Douglas Galasko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 6 | |
| 4 | 7 | |
| 5 | 236 | |
| 6 | 16 | |
| 7 | 6 | |
| 8 | 9 | |
| 9 | 16 | |
| 10 | 244 | |
| 11 | 76 | |
| 12 | 33 | |
| 13 | 179 | |
| 14 | 198 | |
| 15 | 19 | |
| 16 | 33 | |
| 17 | 32 | |
| 18 | 112 | |
| 19 | 317 | |
| 20 | 175 |
About Douglas Galasko
Douglas Galasko is a scholar working on Psychiatry and Mental health, Physiology and Behavioral Neuroscience, having authored 45 papers that have together received 3.3k indexed citations. Recurring topics across this work include Dementia and Cognitive Impairment Research (22 papers), Alzheimer's disease research and treatments (21 papers) and Cholinesterase and Neurodegenerative Diseases (7 papers). The work is most often cited by research in Psychiatry and Mental health (1.5k citations), Physiology (1.7k citations) and Neurology (464 citations). Douglas Galasko has collaborated with scholars based in United States, Canada and Denmark. Frequent co-authors include Eliezer Masliah, L. J. Thal, Lawrence A. Hansen, David P. Salmon, Robert D. Terry, L A Hansen, L. Robert Hill, Robert Katzman, Mark W. Bondi and Nelson Butters. Their work appears in journals such as Science, American Journal of Psychiatry and Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.